Evidence map›Paper›PMID 42773460›Full record

ArticleRespiratory research2026

Correction: Modeled reductions in COPD exacerbation rates, mortality, and related medical costs due to increased SITT adoption: PROMETHEUS Italy.

Pierachille Santus, Bianca Oresta, Davide Finocchiaro, Piergiuseppe De Rosa, John Bell, Melissa Caplen, Jennifer Carioto, Prachi Bhatt, Bruce Pyenson, Alberto Papi

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Pierachille SantusDepartment of Biomedical and Clinical Sciences (DIBIC), Division ofRespiratory Diseases, Università degli Studi di Milano, Ospedale L. Sacco,ASST Fatebenefratelli- Sacco, Milan, Italy.
Bianca OrestaBioPharmaceutical Medical, AstraZeneca, Milan, Italy.
Davide FinocchiaroBioPharmaceuticals Market Access & Government Affairs, AstraZeneca, Milan, Italy.
Piergiuseppe De RosaBioPharmaceutical Medical, AstraZeneca, Milan, Italy.
John BellBioPharmaceutical Medical, AstraZeneca, Cambridge, UK.
Melissa CaplenMilliman, New York, USA.
Jennifer CariotoMilliman, New York, USA. Jennifer.Carioto@milliman.com.
Prachi BhattMilliman, New York, USA.
Bruce PyensonMilliman, New York, USA.
Alberto PapiDepartment of Respiratory Medicine, University of Ferrara MedicalSchool, Ferrara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42773460
PMCPMC13595710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.